1. Understanding the Aftermath of Brexit: Implications for the Pharmaceutical Industry

   • Chie Hoon Song

   Commentary 18 August 2016 Pages: 253 - 256

2. Considerations for Successful Risk-Minimisation Strategies in the EU

   • Janine Collins
   • Dafna Bonneh-Barkay

   Current Opinion 26 September 2016 Pages: 257 - 261

   

3. Strategies and Systems-Level Interventions to Combat or Prevent Drug Counterfeiting: A Systematic Review of Evidence Beyond Effectiveness

   • Racha Fadlallah
   • Fadi El-Jardali
   • Elie A. Akl

   Systematic Review Open access 19 August 2016 Pages: 263 - 276

   

4. Analysis of the Drugs Withdrawn from the US Market from 1976 to 2010 for Safety Reasons

   • Pierre La Rochelle
   • Joel Lexchin
   • David Simonyan

   Original Research Article 12 September 2016 Pages: 277 - 289

   

5. Evaluation of Pharmacovigilance Practice in Pharmaceutical Companies in Nigeria

   • Obiyo Nwaiwu
   • Olayemi Oyelade
   • Chinwe Eze

   Original Research Article 27 July 2016 Pages: 291 - 295

6. Forum

   Update 25 August 2016 Pages: 297 - 310

7. Major Pharmaceutical Conferences and Courses

   Update 16 August 2016 Pages: 311 - 312